Changes Encourage Celltrion And Nan Fung To Bet On China Biosimilars Opportunity

Despite increasing competition, Celltrion has leapt into China's growing biosimilar market through a joint venture with Nan Fung, and another draw could lie in the biologics contract manufacturing potential in the country’s developing Greater Bay Area.